INVENTIVA PHARMA
Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology. They have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
INVENTIVA PHARMA
Industry:
Biopharma Biotechnology Clinical Trials Medical Medical Device
Founded:
2011-01-01
Address:
Daix, Bourgogne, France
Country:
France
Website Url:
http://www.inventivapharma.com
Total Employee:
101+
Status:
Active
Contact:
+33 (0)3 80 44 75 00
Total Funding:
139.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Nginx
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Jean Volatier Chief Financial Officer @ Inventiva Pharma
Chief Financial Officer
Michael Cooreman Chief Medical Officer @ Inventiva Pharma
Chief Medical Officer
Pierre Broqua Co-Founder & CSO @ Inventiva Pharma
Co-Founder & CSO
2012-08-01
Kristina Meyer Head of Business Development @ Inventiva Pharma
Head of Business Development
Frederic Cren Co- Founder & CEO @ Inventiva Pharma
Co- Founder & CEO
2012-07-01
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Inventiva Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Inventiva Pharma
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Inventiva Pharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Inventiva Pharma
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Inventiva Pharma
AbbVie
AbbVie investment in Grant - Inventiva Pharma
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Inventiva Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Inventiva Pharma
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Inventiva Pharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Inventiva Pharma
Official Site Inspections
http://www.inventivapharma.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.22 K
- Host name: vs16.mygoldennetwork.cognix-systems.net
- IP address: 146.59.140.137
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
More informations about "Inventiva Pharma"
Leadership - Inventiva Pharma
In 2001, within the newly created Scientific Affairs Division, she actively participated in the establishment of a new research organization adapted to the Group’s challenges by equipping …See details»
Inventiva Pharma - Crunchbase Company Profile
Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with …See details»
Inventiva Company Profile | Management and Employees List
Inventiva Profile and History Founded in 2012 and headquartered in France, Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule …See details»
Inventiva: Shareholders Board Members Managers and Company …
5 days ago Inventiva is a biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the …See details»
Inventiva Pharma - The Org
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the …See details»
Inventiva S.A. (LON: 0RNK) Company Profile & Overview - Stock …
Jan 23, 2025 Company profile for Inventiva S.A. (LON: 0RNK) with a description, list of executives, contact details and other key facts.See details»
Org Chart Inventiva - The Official Board
The org chart of Inventiva contains its 19 main executives including Frédéric Cren, Jean Volatier and Alice Roudot-Ketelers.See details»
About Inventiva - Inventiva Pharma
We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and …See details»
Inventiva Pharma 2025 Company Profile: Stock …
Information on stock, financials, earnings, subsidiaries, investors, and executives for Inventiva Pharma. Use the PitchBook Platform to explore the full profile.See details»
Inventiva Pharma - LinkedIn
Inventiva Pharma Biotechnology Research A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies.See details»
Inventiva Pharma Information - RocketReach
Inventiva Pharma is a Biotechnology Research, Pharmaceuticals, and Biopharma company located in Daix, Bourgogne-Franche-Comte with $9 million in revenue and 114 employees. …See details»
Inventiva Company Profile - Craft
Oct 29, 2024 Inventiva has 5 employees at their 1 location and €17.48 m in annual revenue in FY 2023. See insights on Inventiva including office locations, competitors, revenue, financials, …See details»
Delving into the Latest Updates on Inventiva SA with Synapse
Inventiva is a public company listed on compartment B of the regulated market of Euronext Paris (ticker: IVA, ISIN: FR0013233012) and on the Nasdaq Global Market in the United States …See details»
Investors - Inventiva Pharma
We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the …See details»
Inventiva reports its 2024 full year results and provides a business ...
5 hours ago Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 m...See details»
Accueil - Inventiva Pharma
Nous sommes une société biopharmaceutique spécialisée dans la découverte et le développement de molécules innovantes administrées par voie orale pour le traitement de …See details»
Inventiva Pharma Company Overview, Contact Details
Oct 14, 2024 Learn more about Inventiva Pharma's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Nextsource | Company Profile | Inventiva Pharma
Explore the company profile of Inventiva Pharma (inventivapharma.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Investor Presentations - Inventiva Pharma
50 rue de Dijon 21121 Daix, France Email: finance@inventivapharma.com Tel: +33 (0)3 80 44 75 00See details»
Inventiva Pharma-动脉网 - vbdata.cn
Jan 1, 2011 Inventiva是一家临床阶段的生物制药公司，专注于开发口服小分子疗法，在纤维化、肿瘤学和孤儿病方面拥有专长。该公司着重关注医疗需求未满足的疾病，如NASH和全身性硬 …See details»